John H. Ford
Deep value, special situations

Why Marathon's Share Price Could Double This Year

A couple of years ago, I received a call from an investment banker and was advised to buy VirnetX (NYSEMKT:VHC) when it was trading at $2 a share. I looked at the company and hated it. There was no way I was going to buy this upstart that was suing Microsoft. What chance would they have? At that time, patent litigation was virtually unknown by Wall Street. VirnetX shares dropped to $1. I felt vindicated. VirnetX was a dog!

But to my surprise, VirnetX prevailed over Microsoft and was awarded a $200 million settlement. I became a convert. I bought shares at $5. The shares rose to $40. Over a two-year period, I traded VirnetX on a regular...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details